ANADYS PHARMACEUTICALS INC 4
4 · ANADYS PHARMACEUTICALS INC · Filed Oct 24, 2011
Insider Transaction Report
Form 4
QVT Associates GP LLC
10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2011-10-21$3.68/sh−364,918$1,342,898→ 5,152,936 total(indirect: Through QVT Fund LP and Quintessence Fund L.P.) - Sale
Common Stock, $0.001 par value
2011-10-20$3.68/sh−5,252,700$19,329,936→ 5,517,854 total(indirect: Through QVT Fund LP and Quintessence Fund L.P.)